Page last updated: 2024-10-27

flutamide and Follicular Thyroid Carcinoma

flutamide has been researched along with Follicular Thyroid Carcinoma in 1 studies

Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.

Research Excerpts

ExcerptRelevanceReference
"To investigate the application value of The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category combined with other ultrasound features of nodules in distinguishing follicular thyroid carcinoma (FTC) from thyroid follicular adenoma (FTA)."1.72ACR TI-RADS classification combined with number of nodules, halo features optimizes diagnosis and prediction of follicular thyroid cancer. ( Hao, SY; Luo, BM; Qiu, Y; Ruan, JL; Tan, L; Wu, SJ; Yang, HY, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wu, SJ1
Tan, L1
Ruan, JL1
Qiu, Y1
Hao, SY1
Yang, HY1
Luo, BM1

Other Studies

1 other study available for flutamide and Follicular Thyroid Carcinoma

ArticleYear
ACR TI-RADS classification combined with number of nodules, halo features optimizes diagnosis and prediction of follicular thyroid cancer.
    Clinical hemorheology and microcirculation, 2022, Volume: 82, Issue:4

    Topics: Adenocarcinoma, Follicular; Flutamide; Humans; Retrospective Studies; Thyroid Neoplasms; Thyroid Nod

2022